Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This article reviews current diagnostic and treatment approaches for androgenetic alopecia but reports no new results, focusing on its progression and medical management options.

This review discusses different clinical forms, laboratory tests, and treatments for female androgenetic alopecia and reports no new results; it emphasizes the importance of proper management.

This article reviews current evaluation and treatment options for androgenic alopecia in women and reports no new clinical results.

This study observed that telogen effluvium was the most common pattern of diffuse hair loss among 100 female patients, often associated with factors like stress and fever.

This study reported that low-dose oral minoxidil combined with a 5α-reductase inhibitor improved hair density in most men with female pattern hair loss after 6 months or more of treatment.

This study found that standardized scalp massages may help stabilize or regrow hair in individuals with androgenic alopecia, as perceived by the participants themselves.

In this study, the authors compared trichoscopy findings for different forms of diffuse non-cicatricial alopecia in females and suggested that trichoscopy might often replace the need for histopathological confirmation, reserving biopsies for more uncertain cases.

This pilot study found that examining changes in scalp scales after scraping may effectively distinguish seborrheic dermatitis associated with androgenetic alopecia from fibrosing alopecia in a pattern distribution.

Diet affects baldness; eat balanced, less animal fat, more fruits, vegetables, and cereals.

This case report highlights the importance of considering telogen effluvium in young men with hair loss resembling male androgenetic alopecia to prevent misdiagnosis and unnecessary treatment.

In this case report, the researchers documented a rare instance of plica neuropathica, characterized by matted and twisted hair, occurring alongside diffuse alopecia, marking the first such documented association and emphasizing its diagnostic challenges in identifying causes of alopecia.

This study reported that most androgenetic alopecia patients in Trujillo were male, aged 31–39, with a family history of the condition, showing specific hair loss patterns and a disease duration of 1–5 years.

In this study, researchers analyzed histopathologic findings in 32 women with chronic diffuse alopecia and found that 40.6% had androgenetic alopecia, while a diffuse variant of lichen planopilaris was diagnosed in 32.5% of cases, emphasizing the importance of histopathologic examination for accurate diagnosis.

Most older adults experience pattern hair loss due to shrinking hair follicles, with men and women showing different balding patterns.

This article discusses androgenetic alopecia, emphasizing its prevalence, characteristics, and the importance of prompt diagnosis and treatment but reports no new clinical results.

This review discusses the pathogenesis and patterns of androgenetic alopecia in men and suggests further research due to the condition's prevalence and implications; it reports no new clinical results.

This article discusses the extent of investigation needed for diffuse alopecia in women but reports no new findings.

This study observed that fibrosing alopecia in a pattern distribution shows varied histological features and may resemble lichen planopilaris with initial diffuse distribution, potentially leading to scarring alopecia.

This case report suggests that transplanted hair follicles may be more resistant to alopecia areata than native hair, potentially offering new insights into the condition's pathophysiology and treatment options.

Two lotions used day and night may be a good alternative to minoxidil for hair loss, with better cosmetic effects and tolerance.

In this study, women treated for androgen-dependent alopecia with CPA EE2 therapy experienced significant decreases in serum vitamin B12, hemoglobin, and hematocrit levels after six months.

This study found that dermoscopy can help differentiate between types of diffuse alopecia in females, with yellow dots common in telogen effluvium and hair diameter diversity over 20% significant in female androgenetic alopecia.

This case report describes a young woman with hypopituitarism who experienced hair loss typical of female androgenetic alopecia without detectable androgens, suggesting this hair loss pattern may not always be androgen dependent.

This study reported that androgenetic alopecia in women becomes more prevalent with age, with risk factors including heredity and endocrine disorders, and differs clinically from male-pattern hair loss by causing diffuse hair thinning rather than loss at the temples or crown.

This case study identified the condition as Monilethrix in a 17-year-old female, characterized by a beaded hair appearance and linked to a genetic cause.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

This study suggests that yellow dots observed in scalp videodermoscopy are not highly specific to alopecia areata, as they appear in various types of alopecia.

Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.

This study reports that permanent and severe alopecia is a newly identified complication of the FEC 100–docetaxel regimen used for adjuvant breast cancer treatment.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.